Loading clinical trials...
Loading clinical trials...
Edwards SAPIEN 3 Transcatheter Heart Valve Therapy for Intermediate Risk Patients
Conditions
Interventions
TAVR
Locations
51
United States
Scripps Green Hospital
La Jolla, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Mercy General Hospital
Sacramento, California, United States
Stanford University Medical Center
Stanford, California, United States
University of Colorado Hospital
Denver, Colorado, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Start Date
February 17, 2014
Primary Completion Date
November 18, 2015
Completion Date
October 9, 2024
Last Updated
January 3, 2025
Lead Sponsor
Edwards Lifesciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions